Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703948 · ClinicalTrials.gov registry record · NA
Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation
A NA study of Lip Augmentation and Correction of Perioral Rhytids, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 4
- Study locations
NCT02703948: Completed NA study of Lip Augmentation and Correction of Perioral Rhytids, sponsored by Galderma R&D.
NCT02703948 is a NA study of Lip Augmentation and Correction of Perioral Rhytids that has completed, run by Galderma R&D. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02703948, a NA study of Lip Augmentation and Correction of Perioral Rhytids, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .
Conditions Studied
Interventions
- DEVICE Restylane Silk with Lidocaine
Study Locations (4)
California
- United States, California - Beverly Hills
- United States, California - San Diego
Florida
- United States, Florida - Miami
Georgia
- United States, Georgia - Roswell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02703948 record still lists
NCT02703948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Lip Augmentation and Correction of Perioral Rhytids appearing as the primary indexed condition, and to 1 intervention - of which Restylane Silk with Lidocaine is the first listed.
NCT02703948 reports a single indexed study location in California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT02703948 about?
NCT02703948 is a clinical study titled "Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation". This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .
What is the current status of trial NCT02703948?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-03. Estimated completion is 2016-08.
What conditions does trial NCT02703948 study?
This clinical trial studies the following conditions: Lip Augmentation and Correction of Perioral Rhytids.
What interventions are being tested in trial NCT02703948?
The interventions under investigation include: Restylane Silk with Lidocaine (DEVICE).
Who is sponsoring clinical trial NCT02703948?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02703948 being conducted?
This trial has 4 study locations across California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02703948's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia